ImmuneXcite, Inc. — Form D/A
ImmuneXcite, Inc. of Waltham, MA, a company, filed a Form D amendment with the SEC on 2017-02-01. The offering totals $10.9M, of which $8.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-02-01
- Form: D/A
- Accession: 0001538550-17-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.9M
- Amount sold: $8.9M
- Remaining: $2.0M
- Investors: 81
- Date of first sale: 2015-11-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-252821
Issuer
- Name: ImmuneXcite, Inc.
- CIK: 0001538550
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 266 2nd Avenue, Waltham, MA, 02451
- Phone: 781-701-8989
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Ann DeWitt | Director | Woburn, MA |
| Eric Rowinsky | Director | Rehovot, L3 |
| Eric Furfine | Director | Watertown, MA |
| Eric Furfine | Executive Officer | Watertown, MA |
| John Edwards | Director | Atlanta, GA |
| John Edwards | Executive Officer | Atlanta, GA |
| James Geraghty | Director | Cambridge, MA |
| David Schechter | Director | Waltham, MA |
| Valerie Friedman | Director | Lexington, MA |
| Yaniv Bejerano | Director | Lexington, MA |
| Yaniv Bejerano | Executive Officer | Lexington, MA |
| Stonberg Jeff | Director | Watertown, MA |
Other filings by this issuer (5)
More